Abiomed
ABMD
#1118
Rank
HK$133.57 B
Marketcap
HK$2,962
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : HK$1.21 Billion

According to Abiomed's latest financial reports the company's total liabilities are HK$1.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31HK$1.33 B3.96%
2021-03-31HK$1.28 B9.36%
2020-03-31HK$1.17 B26.98%
2019-03-31HK$0.92 B21.28%
2018-03-31HK$0.76 B-0.5%
2017-03-31HK$0.76 B78.68%
2016-03-31HK$0.42 B17.82%
2015-03-31HK$0.36 B26.28%
2014-03-31HK$0.28 B12.47%
2013-03-31HK$0.25 B19.2%
2012-03-31HK$0.21 B2.61%
2011-03-31HK$0.20 B24.52%
2010-03-31HK$0.16 B8.42%
2009-03-31HK$0.15 B-18.61%
2008-03-31HK$0.19 B72.77%
2007-03-31HK$0.11 B56.76%
2006-03-31HK$70.21 M84.41%
2005-03-31HK$38.07 M1.3%
2004-03-31HK$37.58 M-22.86%
2003-03-31HK$48.72 M-38.75%
2002-03-31HK$79.54 M9.27%
2001-03-31HK$72.79 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$23.35 B 1,816.71%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$128.27 B 10,425.21%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.16 B-4.28%๐Ÿ‡บ๐Ÿ‡ธ USA